Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
J Bone Miner Res. 2023 Mar;38(3):395-402. doi: 10.1002/jbmr.4759. Epub 2023 Jan 17.
During the menopause transition (MT), lean mass decreases and fat mass increases. We examined the associations of these body composition changes during the MT (2 years before to 2 years after the final menstrual period) with bone mineral density (BMD) at the end of the MT and fracture after the MT. We included 539 participants from the Study of Women's Health Across the Nation who were not taking bone-beneficial or bone-detrimental medications before or during the MT. Using multivariable linear regression, we assessed the independent associations of % lean mass loss and % fat mass gain during the MT (mutually adjusted) with femoral neck (FN) and lumbar spine (LS) BMD at the end of the MT, adjusted for pre-MT BMD, pre-MT lean and fat mass, race/ethnicity, Study of Women's Health Across the Nation (SWAN) study site, age, and cigarette use. We used Cox proportional hazards regression to quantify the relations of % lean loss and % fat gain during the MT with fracture after the MT. The Cox model was adjusted for the covariates above plus post-MT use of bone-detrimental medications, and censored at the first use of bone-beneficial medications; we further controlled for FN or LS BMD at the end of the MT. Adjusted for covariates, each standard deviation (SD) (6.9%) increment in lean mass loss was associated with 0.010 g/cm lower FN BMD (p < 0.0001); each SD (19.9%) increment in fat mass gain was related to 0.026 g/cm greater FN (p = 0.009) and LS (p = 0.03) BMD. Each SD increment in lean mass loss and fat mass gain was associated with 63% (p = 0.001) and 28% (p = 0.05) greater fracture hazard after the MT; associations were essentially unchanged by BMD adjustment. MT-related lean mass loss and fat mass gain were associated differentially with BMD; both were independently related to more fractures. Mitigating MT-related body composition changes may reduce fracture risk. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
在绝经过渡期间(MT),瘦体重减少,脂肪体重增加。我们研究了 MT 期间(末次月经前 2 年至末次月经后 2 年)这些身体成分变化与 MT 结束时骨矿物质密度(BMD)和 MT 后骨折的关系。我们纳入了来自妇女健康全国研究的 539 名参与者,他们在 MT 之前或期间没有服用有益于骨骼或损害骨骼的药物。我们使用多变量线性回归评估了 MT 期间(相互调整)瘦体重损失百分比和脂肪体重增加百分比与 MT 结束时股骨颈(FN)和腰椎(LS)BMD 的独立关联,调整了 MT 前的 BMD、MT 前的瘦体重和脂肪体重、种族/民族、妇女健康全国研究(SWAN)研究地点、年龄和吸烟。我们使用 Cox 比例风险回归来量化 MT 期间瘦体重损失和脂肪体重增加与 MT 后骨折的关系。Cox 模型调整了上述协变量,以及 MT 后使用损害骨骼的药物,并在首次使用有益于骨骼的药物时进行了 censored;我们进一步控制了 MT 结束时 FN 或 LS 的 BMD。调整协变量后,瘦体重损失每增加一个标准差(SD)(6.9%)与 FN 骨密度降低 0.010g/cm 相关(p<0.0001);脂肪质量每增加一个 SD(19.9%)与 FN(p=0.009)和 LS(p=0.03)BMD 增加 0.026g/cm 相关。瘦体重损失和脂肪体重增加的每个 SD 增加与 MT 后骨折风险增加 63%(p=0.001)和 28%(p=0.05)相关;BMD 调整后,相关性基本不变。MT 相关的瘦体重损失和脂肪体重增加与 BMD 差异相关;两者都与更多的骨折独立相关。减轻 MT 相关的身体成分变化可能会降低骨折风险。